The group’s principal activity is to provide pharmaceutical solutions for respiratory, dermatology and psychiatry markets. The group’s product lines include Aquoral, Zinx, Akurza, Xyralid, Extendryl and Levall. Specific customers of the group include IBM, Motorola, HP, BroadVision KPOK, NMS communications, Toshiba and queplix. The revenue of the group in the year 2006, were 3.17 (millions). The group operates from the United States.
